University of Vermont

The University of Vermont Cancer Center

trials_gyno.html

Gynecological Cancer Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on gynecological cancer research.

Status: Active - Recruiting
Study Title: GOG-0286B: A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC #91485) versus Pacllitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, stage IVB, or Recurrent Endometrial Cancer
Purpose: The purpose of this study is to find out if the drug combination of paclitaxel, carboplatin and metformin works better than paclitaxel and carboplatin alone in treating advanced or recurrent endometrial (uterine) cancer and to find out what side effects are caused by treatment with these drugs.
ClinicalTrials.gov Identifier: NCT02065687
Contact: Jennifer Holmes (802) 847-3453
Information: https://clinicaltrials.gov/ct2/show/NCT02065687?term=gog-0286b&rank=1
Institution Number: M14-461
Protocol Research Type: Cooperative Group (GOG)

Last modified December 15 2015 10:23 AM